M&A Deal Summary |
|
|---|---|
| Date | 2017-06-08 |
| Target | iNova Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) |
Pacific Equity Partners
The Carlyle Group Bourne Partners Strategic Capital |
| Sellers(s) | Bausch Health |
| Deal Type | Divestiture |
| Deal Value | 930M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 10.0B AUD |
| Size | Mega |
| Type | Sector Agnostic |
Pacific Equity Partner (PEP) is a private equity firm focused on buyout and late stage expansion capital investments in Australia and New Zealand. PEP typically partners with management teams in acquiring businesses and focuses on transactions valued up to AU$1 Billion. The Firm prefers control situations and typically holds investments for three to six years. PEP will not invest in start-ups or unprofitable businesses, as well as gambling or tobacco companies. Pacific Equity Partners was formed in 1998 and is based in Sydney, Australia. The Firm targets various industries.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 35 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 8 of 10 |
| Country (Singapore) | 1 of 1 |
| Year (2017) | 3 of 3 |
| Size (of disclosed) | 2 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-03-31 |
Pinnacle Bakery & Integrated Ingredients
Newington, Australia Pinnacle Bakery & Integrated Ingredients manufactures and distributes finished backed good, forzen and unbacked specialty products. Pinnacle Bakery & Integrated Ingredients is based in Newington, Australia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-02-06 |
LifeHealthcare
North Ryde, Australia LifeHealthcare is an independent medical device distributor in Australia and New Zealand. The business supplies a diversified product portfolio across multiple therapeutic channels including spine, orthopaedics and neurosurgery, amongst others. LifeHealthcare was founded in 2005 and is based in North Ryde, Australia. |
Buy | $211M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 435.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.
| DEAL STATS | # |
|---|---|
| Overall | 589 of 744 |
| Sector (Life Science) | 9 of 19 |
| Type (Divestiture) | 60 of 72 |
| Country (Singapore) | 2 of 3 |
| Year (2017) | 9 of 29 |
| Size (of disclosed) | 60 of 137 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-06-06 |
Curia
Albany, New York, United States Curia is a provider of global contract research and manufacturing services to the pharmaceutical and biotechnology industries. The company's services include drug discovery, such as medicinal chemistry, discovery biology, and in vitro ADME, development, such as pre-formulation, formulation and validation and manufacturing, such as CGMP API manufacturing. Curia was founded in 1991 and is based in Albany, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-06-09 |
IRCA
Gallarate, Italy IRCA is a manufacturer of ingredients and food products for pastry-making, baking and ice-cream retailing. IRCA was established in 1919 and is based in Gallarate, Italy. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| Size | Small |
| Type | Sector Focused |
Bourne Partners Strategic Capital is the direct investment arm of financial advisory firm Bourne Partners. Strategic Capital looks to partner with other sponsors and management teams to pursue investment opportunities in the pharmaceutical and consumer health sectors. The Group targets a variety of investment situations and will consider transactions valued between $50 million and $1 billion. Bourne Partners Strategic Capital is based in Charlotte, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 5 |
| Sector (Life Science) | 2 of 4 |
| Type (Divestiture) | 1 of 1 |
| Country (Singapore) | 1 of 1 |
| Year (2017) | 2 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-06-06 |
Curia
Albany, New York, United States Curia is a provider of global contract research and manufacturing services to the pharmaceutical and biotechnology industries. The company's services include drug discovery, such as medicinal chemistry, discovery biology, and in vitro ADME, development, such as pre-formulation, formulation and validation and manufacturing, such as CGMP API manufacturing. Curia was founded in 1991 and is based in Albany, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-05-21 |
Millicent Pharma
Dundalk, Ireland Millicent Pharma is a pharmaceutical company that is focused on improving patient lives and outcomes and seeks to acquire, develop, manufacture, and commercialize pharmaceutical products globally. Millicent Pharma was founded in 2018 and is based in Dundalk, Ireland. |
Buy | - |
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 8.8B USD (2023) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 10 |
| Sector (Life Science) | 3 of 3 |
| Type (Divestiture) | 8 of 10 |
| Country (Singapore) | 1 of 1 |
| Year (2017) | 5 of 6 |
| Size (of disclosed) | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-10 |
CeraVe
Bridgewater, New Jersey, United States CeraVe is a developer and manufacturer of skincare products including cleansers, moisturizers, sunscreens and healing ointments. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-10 |
Obagi
Long Beach, California, United States Obagi is a physician-dispensed brand in the dermo-cosmetic space, the highest-growth category in skin care. Obagi's product portfolio includes brands Obagi Nu-Derm®, Condition & Enhance®, Obagi-C® Rx, ELASTIDerm® and CLENZIDerm®. |
Sell | $190M |
